Though it has long been recognized that the liver exhibits remarkable immune tolerance, the underlying mechanisms driving ...

A discovery in mice reveals why fasting enhances a type of breast cancer treatment — a hormone-signalling pathway and gene-expression changes have key roles. Stephen D. Hursting is in the Department ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

Megestrol, which helps treat hot flashes associated with menopause, may have the added benefit of slowing the growth of ...

Z-endoxifen has demonstrated efficacy in phase 1 and 2 trials, improving progression-free survival and tumor response in ...

This comprehensive review synthesizes a decade of human and animal research to explain how the gut and brain communicate ...

Asal Shirazi, Founder of ASA Foundation, shares insights into what drives inflammatory responses, including the role of ...

Thousands of genes that have an influence on weight, say experts - which means weight loss isn't a level playing field ...

Vivoo introduced its conceptual FlowPad at CES, alongside the launch of its smart toilet sensor for hydration detection.

HER2CLIMB-05 trial evaluated Tukysa in combination with Herceptin and Perjeta for HER2-positive metastatic breast cancer, ...

Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing benefits across various patient subgroups. At the 2025 SABCS, researchers ...